echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The Central Office and the State Office issued heavy documents! Involved in pharmaceutical recruitment, API monopoly ...

    The Central Office and the State Office issued heavy documents! Involved in pharmaceutical recruitment, API monopoly ...

    • Last Update: 2021-02-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Pharmaceutical Network February 3, following january 28, the State Office issued to promote the normalization of volume procurement related documents, January 31, the Office of the State Office, the State Office issued a heavy-weight document, many of which related to the pharmaceutical industry.
    January 31, the Central Office and the State Office issued the Action Plan for Building a High Standard Market System, and asked all departments in various regions to implement it in a serious manner, including pharmaceutical recruitment, pharmaceutical patents, monopoly of API and so on.
    program shows that the construction of a high standard market system is an important part of accelerating the improvement of the socialist market economic system, and is of great significance to accelerating the construction of a new development pattern with the domestic and international cycles as the main body and the domestic and international double cycles promoting each other.
    the main points related to the pharmaceutical and medical fields are as follows: 01 Strengthen the protection of intellectual property rights.
    to issue provisions on a number of issues related to the examination and approval of patents in civil cases involving drug listing.
    to study and formulate rules for the protection of intellectual property rights in the field of drug patent protection and cross-border e-commerce, and to prepare and publish guidelines for the protection of intellectual property rights of enterprises and national guidelines for the protection of intellectual property rights.
    strengthen and improve antitrust and anti-unfair competition enforcement.
    firmly oppose monopoly and unfair competition.
    to formulate anti-monopoly guidelines in special areas such as raw materials and pharmaceuticals, and to apply the exemption system, and issue guidelines for the implementation of anti-monopoly compliance outside the enterprise.
    03 To accelerate the construction of medical security information system, build a unified, multi-level interconnection data sharing and exchange system, and promote cross-regional, cross-level, cross-sectoral business coordination.
    04 promote the development of new service platforms such as Internet medical care, online education, third-party logistics, instant delivery, online office, online work, etc., and effectively play the role of platform enterprises in the optimization and integration of factor configuration.
    05 to expand the opening of the social services market in an orderly manner.
    focus on medical care, education, sports, child care, environmental protection, municipal and other fields, reduce market access restrictions, remove unreasonable restrictions on for-profit medical care, education and other institutions in the processing of certification, equipment acquisition and so on.
    improve the way medical institutions are planned, implement guiding plans for social-run medical institutions, and strengthen the services of social capital investment in medical institutions.
    06 to vigorously promote the credit classification classification supervision.
    To promote tax administration, import and export, ecological environmental protection, medical security, pharmaceutical recruitment and other key areas in-depth implementation of credit classification supervision, according to the credit status of regulatory objects to take differentiated regulatory measures to provide market subjects with more accurate and convenient services.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.